[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2009, 35(1) 16-18 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
���Ժ�ɫ����;Ƥ��ɫ�ؼ���
���������������
л־��
������
PubMed
Article by
Article by

���Ժ�������Ƥ��ɫ�ؼ���

л־�� ������

����ҽԺƤ����

ժҪ��

���Ժ������ɰ��ж���Ƥ��ɫ�ؼ��˵ı��֣��䷢���ʸ�����ͨ��Ⱥ���鷢�ߵ�Ԥ����ԽϺá����ƿ����Ƕ�ͬʱ��������������ϸ���ͺ�����ϸ���ϵĺ��ع�ͬ��ԭ���߷�Ӧ�Ľ��������һ�ֿ�����ҩ������Ӧ��ɫ������Χ��Զ��ͻȻ���ְ�����Ƥ�������Ƥ��ɫ�ؼ��ˣ���������ͨ��Ⱥ���ڷ��ֶ��Ժ��������ѻ��ж��Ժ����������ڷ���ת�ơ�

�ؼ����� ���Ժ�ɫ����;Ƥ��ɫ�ؼ���  

Malignant melanoma and cutaneous depigmentation

Abstract:

Many kinds of cutaneous hypopigmentation may appear in patients with malignant melanoma, with a relatively higher incidence compared with general population. The appearance of hypopigmentation may predict a better prognosis of malignant melanoma. This depigmentation could be either a consequence of dualistic immune-mediated response against common antigens shared by normal melanocytes and malignant melanoma cells, or a kind of antineoplastic-like reaction. The sudden emergence of vitiligo-like hypopigmentation or halo nevi near or apart from preexisting melanocytic nevi or malignant melanoma, may benefit the early diagnosis of malignant melanoma and its metastasis.

Keywords: Malignant melanoma;Hypopigmentation  
�ո����� 2008-05-13 �޻����� 2008-06-13 ����淢������  
DOI:
������Ŀ:

ͨѶ����: л־��
���߼��:

�ο����ף�
�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־